Author:
Hylek Elaine M.,Held Claes,Alexander John H.,Lopes Renato D.,De Caterina Raffaele,Wojdyla Daniel M.,Huber Kurt,Jansky Petr,Steg Philippe Gabriel,Hanna Michael,Thomas Laine,Wallentin Lars,Granger Christopher B.
Funder
Bristol-Myers Squibb and Pfizer
AstraZeneca, Merck, GlaxoSmithKline, Roche, and Bristol-Myers Squibb
Bristol-Myers Squibb, Merck, and Regado Biosciences
Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo
Sanofi-Aventis, Boehringer Ingelheim, Bayer, Bristol-Myers Squibb/Pfizer, and Daiichi Sankyo
Servier, Sanofi, and New York University School of Medicine
AstraZeneca, Merck, Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, and GlaxoSmithKline
Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic Foundation, Merck & Co, Pfizer, Sanofi-Aventis, Takeda, and The Medicines Company
Subject
Cardiology and Cardiovascular Medicine